Effect of IgY on Periodontitis and Halitosis Induced by
Overview
Microbiology
Affiliations
is a morbific agent in periodontitis and halitosis. Egg yolk antibody (IgY) was obtained from egg yolks from chickens stimulated with . This study was to assess the effectiveness of IgY on periodontitis and halitosis caused by in vitro and in vivo. The growth of was inhibited ( <0. 05) by different concentrations of IgY in vitro and the results of a Halimeter show volatile sulfur compounds (VSCs) were reduced to 904 ± 57 ppb at a concentration 40 mg/ml of IgY. The changes of fatty acids of were determined using GC-MS. The scores for odor index of rat saliva were decreased. The major constituent of volatile organic compounds (VOCs) including short-chain acids decreased 46.2% in 10 mg/ml IgY, ammonia decreased 70% in 40 mg/ml IgY, while aldehydes and olefine ketones were almost unchanged. The ELISA assay revealed that IL-6 and TNF-α were decreased after 4 weeks' IgY treatment. Morphometric (X-ray) and histological analyses (HE) showed that IgY reduced alveolar bone loss and collagen fibers became orderly in rat models. As a result, IgY may have the potential to treat periodontitis and halitosis.
Isah M, Yuzhang H, Dang M, Zhang X Poult Sci. 2025; 104(2):104804.
PMID: 39813868 PMC: 11782816. DOI: 10.1016/j.psj.2025.104804.
Akkermansia muciniphila inhibited the periodontitis caused by Fusobacterium nucleatum.
Song B, Xian W, Sun Y, Gou L, Guo Q, Zhou X NPJ Biofilms Microbiomes. 2023; 9(1):49.
PMID: 37460552 PMC: 10352368. DOI: 10.1038/s41522-023-00417-0.
IgYs: on her majesty's secret service.
Grzywa R, Lupicka-Slowik A, Sienczyk M Front Immunol. 2023; 14:1199427.
PMID: 37377972 PMC: 10291628. DOI: 10.3389/fimmu.2023.1199427.
Novel extraction technologies and potential applications of egg yolk proteins.
Gu L, Liu Y, Zhang W, Li J, Chang C, Su Y Food Sci Biotechnol. 2023; 32(2):121-133.
PMID: 36590017 PMC: 9795146. DOI: 10.1007/s10068-022-01209-6.
IgY Antibodies as Biotherapeutics in Biomedicine.
Leon-Nunez D, Vizcaino-Lopez M, Escorcia M, Correa D, Perez-Hernandez E, Gomez-Chavez F Antibodies (Basel). 2022; 11(4).
PMID: 36278615 PMC: 9590010. DOI: 10.3390/antib11040062.